Follow the 삼성제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성제약 has recorded 19 reports. The latest transaction was disclosed on 8 January 2026 (Other). Among the most active insiders: 젬백스. The full history is free.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.